U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 022159
Company: SEPTODONT HOLDING
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ORAVERSE PHENTOLAMINE MESYLATE 0.4MG/1.7ML INJECTABLE;INJECTION Prescription None Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
05/09/2008 ORIG-1 Approval Type 3 - New Dosage Form STANDARD Letter (PDF)
Review
Summary Review (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022159s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022159_oraverse_toc.cfm https://www.accessdata.fda.gov/drugsatfda_docs/summary_review/2008/022159s000_SUMR.pdf
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
01/07/2016 SUPPL-12 Manufacturing (CMC)

Label is not available on this site.

03/18/2016 SUPPL-11 Efficacy-New Patient Population Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022159s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/022159Orig1s011ltr.pdf
01/26/2015 SUPPL-10 Manufacturing (CMC)

Label is not available on this site.

01/26/2015 SUPPL-9 Manufacturing (CMC)

Label is not available on this site.

01/05/2015 SUPPL-8 Manufacturing (CMC)

Label is not available on this site.

04/09/2014 SUPPL-7 Manufacturing (CMC)

Label is not available on this site.

09/09/2013 SUPPL-6 Manufacturing (CMC)

Label is not available on this site.

01/09/2014 SUPPL-5 Manufacturing (CMC)

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
03/18/2016 SUPPL-11 Efficacy-New Patient Population Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022159s011lbl.pdf
Back to Top